This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Intervet International B.v.. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Innovations of Tobias Letzel in Viral Research
Introduction
Tobias Letzel is a notable inventor based in Eberswalde, Germany. He has made significant contributions to the field of viral research, particularly in the study of infectious bursal disease virus (IBDV). His work has implications for both classic and variant strains of the virus, showcasing his expertise in virology.
Latest Patents
Tobias Letzel holds a patent for an "Infectious bursal disease virus (IBDV) mutant expressing virus neutralising epitopes specific for classic-and variant IBDV strains." This invention provides a classic IBDV mutant that additionally comprises virus neutralising epitopes specific for variant-E IBDV. This advancement is crucial for developing effective vaccines and treatments for IBDV.
Career Highlights
Letzel is associated with Intervet International B.V., a company known for its focus on animal health and veterinary pharmaceuticals. His role at the company allows him to apply his innovative ideas in a practical setting, contributing to advancements in veterinary medicine.
Collaborations
Throughout his career, Tobias has collaborated with notable colleagues such as Egbert Mundt and Guntram Paul. These collaborations have fostered a productive environment for research and innovation in the field of virology.
Conclusion
Tobias Letzel's work exemplifies the intersection of innovation and practical application in viral research. His contributions, particularly in the development of IBDV mutants, are paving the way for future advancements in veterinary health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile